Tumor Vessel Development and Maturation Impose Limits on the Effectiveness of Anti-Vascular Therapy
- 1 January 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 162 (1) , 183-193
- https://doi.org/10.1016/s0002-9440(10)63809-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in TumorsPublished by Elsevier ,2002
- Effect of p53 Status on Tumor Response to Antiangiogenic TherapyScience, 2002
- Heterogeneous Vascular Dependence of Tumor Cell PopulationsThe American Journal of Pathology, 2001
- Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survivalThe FASEB Journal, 2001
- Openings between Defective Endothelial Cells Explain Tumor Vessel LeakinessThe American Journal of Pathology, 2000
- Blood vessel maturation: vascular development comes of ageJournal of Clinical Investigation, 1999
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agentsBioEssays, 1991
- Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic studyDevelopmental Biology, 1974
- Anti-AngiogenesisAnnals of Surgery, 1972